Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome
Authors:
Open Access
- 2 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (2) , 176-182
Abstract
Objective. To determine the outcome of paediatric SLE (pSLE) patients with nephritis who developed acute renal failure (ARF). Efficacy and safety of treatment regimens were compared. Methods. A total of 249 pSLE patients were diagnosed and prospectively followed at a single centre between July 1973 and July 2003; 127 children (51%) had lupus nephritis. ARF was defined as serum creatinine of >250 μmol/l or >75% above baseline. Standardized assessments included clinical data and medications, laboratory testing, disease activity and damage scores were obtained. Subsequent renal flares were documented. Primary outcome: renal function at last follow-up. Secondary outcomes: treatment efficacy and safety. AZA- and cyclophosphamide (CYCLO)-treated patients were compared. Propensity score methods were applied to balance covariates. An intention to treat approach was chosen. Results. The ARF study cohort included 50 patients; 13 boys and 37 girls with a median age of 13.2 yrs at diagnosis and a mean follow-up of 45 months. Renal histology: Class III nephritis in 16; Class IV in 34. Dialysis requirement and disease activity were similar in both groups. Treatment: AZA in 33 patients, CYCLO in 9 and corticosteroids only in 8. Outcome: no statistically significant or clinically relevant differences were found for any of the outcome measures including last serum creatinine, time to renal flare, overall renal survival, disease activity over time, disease damage, mean annual corticosteroid dose and rate of infection. Conclusion. The treatment of renal failure in this pSLE cohort was associated with an excellent outcome. AZA and CYCLO were equally efficacious.Keywords
This publication has 24 references indexed in Scilit:
- Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus NephritisNew England Journal of Medicine, 2005
- Long-Term Study of Mycophenolate Mofetil as Continuous Induction and Maintenance Treatment for Diffuse Proliferative Lupus NephritisJournal of the American Society of Nephrology, 2005
- Intravenous cyclophosphamide for lupus nephritis in Thai childrenScandinavian Journal of Rheumatology, 2004
- Systemic lupus erythematosus in Trinidadian childrenPaediatrics and International Child Health, 2004
- EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisAnnals of the Rheumatic Diseases, 2004
- Lupus nephritis in childhood: a review of 53 patients followed at a single centerPediatric Nephrology, 2003
- Renal Involvement in Systemic Lupus Erythematosus: A Study of 180 Patients from a Single CenterMedicine, 1999
- Lupus nephritis in childrenIndian Journal of Pediatrics, 1999
- Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosusLupus, 1997
- Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United StatesThe Journal of Pediatrics, 1993